Latest Compugen News & Updates

See the latest news and media coverage for Compugen. We track all announcements, press releases, and industry mentions in real time, all in one place.

Compugen

Clinical-stage biotech company discovering cancer immunotherapies

cgen.com

Headquarters: Holon, Israel
Company type: Public company
Number of employees: 100–200

Last updated Today

Latest news about Compugen

In short: Compugen advanced its oncology pipeline and strengthened its financial position through significant partnerships with Gilead and AstraZeneca.

Company announcements

May 18 Compugen

Compugen reported Q1 2026 financial results and pipeline progress

Cash runway extends into 2029; COM701 MAIA-ovarian trial actively enrolling; partners AstraZeneca and Gilead advancing programs.

March 2 Compugen

Compugen reports Q4 and full year 2025 results

Strengthened financial position via AstraZeneca deal and advanced clinical pipeline with COM701 and GS-0321.

18 December 2025 Compugen

Compugen monetizes portion of rilvegostomig royalties

The deal provides $65 million upfront plus $25 million milestone, preserves majority royalties, and is expected to extend cash runway into 2029.

10 November 2025 Compugen

Compugen reports third quarter 2025 financial results

The company posted a net loss of $6.98 million and provided clinical pipeline updates, with cash runway into Q3 2027.

Media coverage

May 25 Investing.com

Earnings call transcript: Compugen’s Q1 2026 revenue beats forecast, stock rises By Investing.com

Earnings call transcript: Compugen’s Q1 2026 revenue beats forecast, stock rises...

Never miss news about Compugen

Track Compugen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Compugen competitors & trending companies

Browse news for competitors to Compugen and other trending companies.